Ammar Al-Chalabi

King’s College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Medical Science Medical Science professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (21)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (26)

Janet E. Cade

University of Leeds

UNITED KINGDOM

View details

Silia Vitoratou

King’s College London

UNITED KINGDOM

View details

Pamela Shaw

University of Sheffield

UNITED KINGDOM

View details

Cathryn Lewis

King’s College London

UNITED KINGDOM

View details

Esther Hobson

Senior clinical lecturer

University of Sheffield

UNITED KINGDOM

View details

Zachary Simmons

UNITED STATES

View details

Stephen Goutman

Associate Professor

University of Michigan

UNITED STATES

View details

Ahmad Al Khleifat

King’s College London

UNITED KINGDOM

View details

K Ray Chaudhuri

King’s College London

UNITED KINGDOM

View details

Martin R Turner

University of Oxford

UNITED KINGDOM

View details

Sarah Opie-Martin

King’s College London

UNITED KINGDOM

View details

Peter Munch Andersen

Professor of Neurology (67% of time)

Umea University

SWEDEN

View details

Mark Coulson

Professor of Psychology

University of West London

UNITED KINGDOM

View details

richard dobson

King’s College London

UNITED KINGDOM

View details

Carolyn Young

Professor of clinical neurology

University of Liverpool

UNITED KINGDOM

View details

Jonathan Woodward

University of Sheffield

UNITED KINGDOM

View details

Kevin Talbot

University of Oxford

UNITED KINGDOM

View details

Rubika Balendra

University College London

UNITED KINGDOM

View details

philippe corcia

Professeur

Université François-Rabelais

FRANCE

View details

Caroline Ingre

Karolinska Institutet

SWEDEN

View details

D. Kevin Horton

Branch Chief

Centers for Disease Control and Prevention

UNITED STATES

View details

Alfredo Iacoangeli

King’s College London

UNITED KINGDOM

View details

Deirdre Murray

McKeon Assistant Professor in Clinical Measurement

Trinity College Dublin

IRELAND

View details

Jeremy M. Shefner

University of Arizona

UNITED STATES

View details

Adriano Chio

Professor of Neurology

University of Turin

ITALY

View details

Silvia Rota

King’s College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ammar Al-Chalabi

Research Interests

Explore related searches

Contact this professor

Articles (21)

Predicting ALS informant distress from cognitive and behavioural change in people with ALS

Amyotrophic Lateral Sclerosis as a Multistep Process in the United States: A Population‐Based Study

Randomised controlled trial with parallel process evaluation and health economic analysis to evaluate a nutritional management intervention, OptiCALS, for patients with amyotrophic lateral sclerosis: study protocol

Respiratory measurements, respiratory symptoms, and quality of life in ALS: results from the REVEALS study

The ethics of self-experimentation: What is the right thing to do? Self-designed gene therapy

The use of genetic testing in amyotrophic lateral sclerosis (ALS): a practical approach

Persistent high levels of perceived fatigue are not associated with hypermetabolism in patients with amyotrophic lateral sclerosis

Hospitalizations as an outcome measure in COURAGE-ALS

Real-world prognostic role of riluzole use in ALS: a multi-center study from PRECISION-ALS

An open-label Phase 2a study to assess the safety and tolerability of trimetazidine in patients with amyotrophic lateral sclerosis

COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success

Non-motor symptoms in amyotrophic lateral sclerosis: lessons from Parkinson’s disease

DNAscan2: a versatile, scalable, and user-friendly analysis pipeline for human next-generation sequencing data

Comparison Of King’s Clinical Staging In Multinational Amyotrophic Lateral Sclerosis Cohorts

A roadmap to ALS prevention: strategies and priorities

Impact of the covid-19 pandemic on amyotrophic lateral sclerosis care in the UK

Reply: A new diagnostic entity must enable earlier treatment in gene carriers

Measuring disability in amyotrophic lateral sclerosis/motor neuron disease: the WHODAS 2.0-36, WHODAS 2.0-32, and WHODAS 2.0-12

Non-motor symptoms in amyotrophic lateral sclerosis

Calculating variant penetrance from family history of disease and average family size in population-scale data

Prevalence of depression in amyotrophic lateral sclerosis/motor neuron disease: multi-attribute ascertainment and trajectories over 30 months.

Collaborators (26)

Janet E. Cade

Silia Vitoratou

Pamela Shaw

Cathryn Lewis

Esther Hobson

Zachary Simmons

Stephen Goutman

Ahmad Al Khleifat

K Ray Chaudhuri

Martin R Turner

Sarah Opie-Martin

Peter Munch Andersen

Mark Coulson

richard dobson

Carolyn Young

Jonathan Woodward

Kevin Talbot

Rubika Balendra

philippe corcia

Caroline Ingre

D. Kevin Horton

Alfredo Iacoangeli

Deirdre Murray

Jeremy M. Shefner

Adriano Chio

Silvia Rota

Make your next move.